Surgeons converge on Barossa for annual conference miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
But Australia must commit to building its sovereign AI research and innovation capability, or risk being left behind as other countries race to pursue their ambitious AI strategies, the authors say.Artificial intelligence: Your Questions Answered has
Share
South Australia is uniquely placed to play a vital role in expediting the nation’s COVID-19 vaccine rollout.
The state has the capability to produce mRNA vaccines, similar to the Pfizer vaccine against COVID-19, within 12 months at a local advanced manufacturing facility. The initiative would be driven by international biotech company BioCina, leveraging the complementary research, technological and clinical trials expertise of the University of Adelaide and SAHMRI.
BioCina CEO Ian Wisenberg says the university and medical research institute’s strengths were a key factor in his company’s recent decision to purchase Pfizer’s biologics manufacturing plant at Thebarton.